462 related articles for article (PubMed ID: 32948688)
1. Impaired Cytotoxic CD8
Westmeier J; Paniskaki K; Karaköse Z; Werner T; Sutter K; Dolff S; Overbeck M; Limmer A; Liu J; Zheng X; Brenner T; Berger MM; Witzke O; Trilling M; Lu M; Yang D; Babel N; Westhoff T; Dittmer U; Zelinskyy G
mBio; 2020 Sep; 11(5):. PubMed ID: 32948688
[TBL] [Abstract][Full Text] [Related]
2. Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity.
Kang CK; Han GC; Kim M; Kim G; Shin HM; Song KH; Choe PG; Park WB; Kim ES; Kim HB; Kim NJ; Kim HR; Oh MD
Int J Infect Dis; 2020 Aug; 97():313-321. PubMed ID: 32492530
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute
Herrmann M; Schulte S; Wildner NH; Wittner M; Brehm TT; Ramharter M; Woost R; Lohse AW; Jacobs T; Schulze Zur Wiesch J
Front Immunol; 2020; 11():1870. PubMed ID: 32983106
[TBL] [Abstract][Full Text] [Related]
4. Suboptimal SARS-CoV-2-specific CD8
Habel JR; Nguyen THO; van de Sandt CE; Juno JA; Chaurasia P; Wragg K; Koutsakos M; Hensen L; Jia X; Chua B; Zhang W; Tan HX; Flanagan KL; Doolan DL; Torresi J; Chen W; Wakim LM; Cheng AC; Doherty PC; Petersen J; Rossjohn J; Wheatley AK; Kent SJ; Rowntree LC; Kedzierska K
Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24384-24391. PubMed ID: 32913053
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 pneumonia: CD8
Jiang Y; Wei X; Guan J; Qin S; Wang Z; Lu H; Qian J; Wu L; Chen Y; Chen Y; Lin X
Clin Immunol; 2020 Sep; 218():108516. PubMed ID: 32574709
[TBL] [Abstract][Full Text] [Related]
6. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia.
De Biasi S; Meschiari M; Gibellini L; Bellinazzi C; Borella R; Fidanza L; Gozzi L; Iannone A; Lo Tartaro D; Mattioli M; Paolini A; Menozzi M; Milić J; Franceschi G; Fantini R; Tonelli R; Sita M; Sarti M; Trenti T; Brugioni L; Cicchetti L; Facchinetti F; Pietrangelo A; Clini E; Girardis M; Guaraldi G; Mussini C; Cossarizza A
Nat Commun; 2020 Jul; 11(1):3434. PubMed ID: 32632085
[TBL] [Abstract][Full Text] [Related]
7. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome.
Weiskopf D; Schmitz KS; Raadsen MP; Grifoni A; Okba NMA; Endeman H; van den Akker JPC; Molenkamp R; Koopmans MPG; van Gorp ECM; Haagmans BL; de Swart RL; Sette A; de Vries RD
Sci Immunol; 2020 Jun; 5(48):. PubMed ID: 32591408
[TBL] [Abstract][Full Text] [Related]
8. Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses.
Zhou R; To KK; Wong YC; Liu L; Zhou B; Li X; Huang H; Mo Y; Luk TY; Lau TT; Yeung P; Chan WM; Wu AK; Lung KC; Tsang OT; Leung WS; Hung IF; Yuen KY; Chen Z
Immunity; 2020 Oct; 53(4):864-877.e5. PubMed ID: 32791036
[TBL] [Abstract][Full Text] [Related]
9. Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73
Ahmadi P; Hartjen P; Kohsar M; Kummer S; Schmiedel S; Bockmann JH; Fathi A; Huber S; Haag F; Schulze Zur Wiesch J
Cells; 2020 Jul; 9(8):. PubMed ID: 32707842
[TBL] [Abstract][Full Text] [Related]
10. Single-cell landscape of immunological responses in patients with COVID-19.
Zhang JY; Wang XM; Xing X; Xu Z; Zhang C; Song JW; Fan X; Xia P; Fu JL; Wang SY; Xu RN; Dai XP; Shi L; Huang L; Jiang TJ; Shi M; Zhang Y; Zumla A; Maeurer M; Bai F; Wang FS
Nat Immunol; 2020 Sep; 21(9):1107-1118. PubMed ID: 32788748
[TBL] [Abstract][Full Text] [Related]
11. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent.
Mazzoni A; Salvati L; Maggi L; Capone M; Vanni A; Spinicci M; Mencarini J; Caporale R; Peruzzi B; Antonelli A; Trotta M; Zammarchi L; Ciani L; Gori L; Lazzeri C; Matucci A; Vultaggio A; Rossi O; Almerigogna F; Parronchi P; Fontanari P; Lavorini F; Peris A; Rossolini GM; Bartoloni A; Romagnani S; Liotta F; Annunziato F; Cosmi L
J Clin Invest; 2020 Sep; 130(9):4694-4703. PubMed ID: 32463803
[TBL] [Abstract][Full Text] [Related]
12. Immunological features of coronavirus disease 2019 in patients with cancer.
Thibaudin M; Fumet JD; Bon M; Hampe L; Limagne E; Ghiringhelli F
Eur J Cancer; 2020 Nov; 139():70-80. PubMed ID: 32977223
[TBL] [Abstract][Full Text] [Related]
13. Immunological and inflammatory profiles in mild and severe cases of COVID-19.
Song JW; Zhang C; Fan X; Meng FP; Xu Z; Xia P; Cao WJ; Yang T; Dai XP; Wang SY; Xu RN; Jiang TJ; Li WG; Zhang DW; Zhao P; Shi M; Agrati C; Ippolito G; Maeurer M; Zumla A; Wang FS; Zhang JY
Nat Commun; 2020 Jul; 11(1):3410. PubMed ID: 32641700
[TBL] [Abstract][Full Text] [Related]
14. Broad and strong memory CD4
Peng Y; Mentzer AJ; Liu G; Yao X; Yin Z; Dong D; Dejnirattisai W; Rostron T; Supasa P; Liu C; López-Camacho C; Slon-Campos J; Zhao Y; Stuart DI; Paesen GC; Grimes JM; Antson AA; Bayfield OW; Hawkins DEDP; Ker DS; Wang B; Turtle L; Subramaniam K; Thomson P; Zhang P; Dold C; Ratcliff J; Simmonds P; de Silva T; Sopp P; Wellington D; Rajapaksa U; Chen YL; Salio M; Napolitani G; Paes W; Borrow P; Kessler BM; Fry JW; Schwabe NF; Semple MG; Baillie JK; Moore SC; Openshaw PJM; Ansari MA; Dunachie S; Barnes E; Frater J; Kerr G; Goulder P; Lockett T; Levin R; Zhang Y; Jing R; Ho LP; ; ; Cornall RJ; Conlon CP; Klenerman P; Screaton GR; Mongkolsapaya J; McMichael A; Knight JC; Ogg G; Dong T
Nat Immunol; 2020 Nov; 21(11):1336-1345. PubMed ID: 32887977
[TBL] [Abstract][Full Text] [Related]
15. Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients.
Urra JM; Cabrera CM; Porras L; Ródenas I
Clin Immunol; 2020 Aug; 217():108486. PubMed ID: 32479985
[TBL] [Abstract][Full Text] [Related]
16. The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z
JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595
[TBL] [Abstract][Full Text] [Related]
17. A Case of Critically Ill Infant of Coronavirus Disease 2019 With Persistent Reduction of T Lymphocytes.
Qiu L; Jiao R; Zhang A; Chen X; Ning Q; Fang F; Zeng F; Tian N; Zhang Y; Huang Y; Sun Z; Dhuromsingh M; Li H; Li Y; Xu R; Chen Y; Luo X
Pediatr Infect Dis J; 2020 Jul; 39(7):e87-e90. PubMed ID: 32379199
[TBL] [Abstract][Full Text] [Related]
18. Reappearance of effector T cells is associated with recovery from COVID-19.
Odak I; Barros-Martins J; Bošnjak B; Stahl K; David S; Wiesner O; Busch M; Hoeper MM; Pink I; Welte T; Cornberg M; Stoll M; Goudeva L; Blasczyk R; Ganser A; Prinz I; Förster R; Koenecke C; Schultze-Florey CR
EBioMedicine; 2020 Jul; 57():102885. PubMed ID: 32650275
[TBL] [Abstract][Full Text] [Related]
19. Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.
Rydyznski Moderbacher C; Ramirez SI; Dan JM; Grifoni A; Hastie KM; Weiskopf D; Belanger S; Abbott RK; Kim C; Choi J; Kato Y; Crotty EG; Kim C; Rawlings SA; Mateus J; Tse LPV; Frazier A; Baric R; Peters B; Greenbaum J; Ollmann Saphire E; Smith DM; Sette A; Crotty S
Cell; 2020 Nov; 183(4):996-1012.e19. PubMed ID: 33010815
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Wei J; Zhao J; Han M; Meng F; Zhou J
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
